Form 4: Vicarious Surgical CEO Sells Shares for Tax Obligations

Vicarious Surgical Inc. CEO Adam David Sachs reported the sale of 463 shares of Class A Common Stock to cover tax withholding obligations related to the vesting of restricted stock units.

Summary

• Adam David Sachs, CEO, Director, and 10% Owner of Vicarious Surgical Inc. (RBOT), filed a Form 4.
• The filing reports the sale of 463 shares of Class A Common Stock on June 3, 2025.
• The shares were sold at a weighted average price of $7.2193 per share, with individual trades ranging from $7.01 to $7.52.
• The purpose of the sale was to cover tax withholding obligations associated with the vesting of restricted stock units granted on June 2, 2023.
• Following this transaction, Mr. Sachs beneficially owns 50,723 shares of Class A Common Stock directly.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While it's a sale of shares by an insider, it's explicitly stated to be for tax withholding purposes related to RSU vesting, which is a routine and non-discretionary event, rather than a sale indicating a lack of confidence in the company's future.

Positives

• The sale was non-discretionary, specifically to cover tax withholding obligations, rather than a discretionary sale indicating a change in confidence.

Negatives

• A minor reduction in direct beneficial ownership by a key insider (463 shares out of 50,723 remaining).

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Management Comments

• The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on June 2, 2023.
• The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

Industry Context

This filing represents a routine insider transaction for tax purposes, common across industries when equity compensation vests. It does not reflect broader industry trends or competitive positioning.

Comparison to Industry Standards

• This is a standard Form 4 filing for an insider transaction to cover tax obligations upon RSU vesting, a common practice for executives receiving equity compensation across publicly traded companies. There are no specific comparable companies or projects mentioned in this filing to assess against industry benchmarks.

Stakeholder Impact

• Shareholders: A very minor reduction in insider ownership, but the non-discretionary nature of the sale mitigates concerns about management confidence.

Next Steps

• The reporting person has undertaken to provide full information about the number of shares sold at each separate price upon request to the SEC staff, Vicarious Surgical Inc., or any security holder.

Key Dates

Keywords

Vicarious Surgical, RBOT, Form 4, Insider Trading, Stock Sale, Adam David Sachs, CEO, Restricted Stock Units, Tax Withholding, Equity Compensation